Somerville P J, Kaye M
Kidney Int. 1979 Nov;16(5):552-60. doi: 10.1038/ki.1979.165.
An animal model was developed to examine the cause of resistance to the calcemic action of PTH in renal failure. Thyroparathyroidectomized (TPTX) rats were repeatedly reinfused with their excreted urine, over a 5-hour period, to produce an acute uremic animal with normal kidneys. Nonuremic controls were infused with equivalent volumes of a simple electrolyte solution. Using this model, we have demonstrated impaired calcemic response to PTH (Lilly Parathyroid Extract, 80 U/100 g) in urine-infused rats compared with electrolyte-infused rats. The final plasma calcium concentrations were 12.0 +/- 0.3 and 14.9 +/- 0.3 mg/dl, respectively (P less than 0.001). The cause of this impaired calcemic response was investigated by reinfusing rats with their own urine that had been pretreated with either activated charcoal or zirconium oxide in two different anionic forms, or urine that had been ultrafiltrated through an Amicon membrane of which the stated molecular-weight cut-off of the smallest pore-size membrane was 500 daltons. It was found that charcoal and ultrafiltration techniques had no effect, whereas the zirconium oxide treatment completely corrected the impaired calcemic response and returned the plasma phosphorus to a concentration similar to that in nonuremic controls. This can be explained by the fact that the principal effect of zirconium oxide on urine is to remove inorganic phosphate. Other groups of TPTX rats given PTH extract were infused with an electrolyte solution containing varying amounts of phosphate up to a maximum similar to the amount that a urine-infused rat would receive. A highly significant inverse relationship was found between the dose of phosphate infused with the electrolyte solution and the measured calcemic response to PTH. This relationship is represented by the following equation: calcium (mg/dl) = 14.84 - 0.139 inorganic phosphate; r = 0.915, P less than 0.001. From these series of studies, we conclude that phosphate retention is the cause of resistance to the calcemic action of PTH extract in this acute uremic model.
为研究肾衰竭时对甲状旁腺激素(PTH)钙调节作用产生抵抗的原因,建立了一种动物模型。将甲状腺甲状旁腺切除(TPTX)大鼠在5小时内反复输注其排出的尿液,以制造肾脏正常的急性尿毒症动物。非尿毒症对照组输注等量的简单电解质溶液。利用该模型,我们发现与输注电解质的大鼠相比,输注尿液的大鼠对PTH(礼来甲状旁腺提取物,80 U/100 g)的钙调节反应受损。最终血浆钙浓度分别为12.0±0.3和14.9±0.3 mg/dl(P<0.001)。通过给大鼠重新输注经以下处理的自身尿液来研究这种钙调节反应受损的原因:用活性炭或两种不同阴离子形式的氧化锆预处理的尿液,或通过Amicon膜超滤的尿液,该膜最小孔径的标称分子量截留值为500道尔顿。结果发现,活性炭和超滤技术无效,而氧化锆处理完全纠正了受损的钙调节反应,并使血浆磷浓度恢复到与非尿毒症对照组相似的水平。这可以用氧化锆对尿液的主要作用是去除无机磷酸盐这一事实来解释。给其他几组接受PTH提取物的TPTX大鼠输注含有不同量磷酸盐的电解质溶液,直至最大量与输注尿液的大鼠所接受的量相似。发现输注电解质溶液中的磷酸盐剂量与测得的对PTH的钙调节反应之间存在高度显著的负相关。这种关系由以下方程表示:钙(mg/dl)=14.84 - 0.139×无机磷酸盐;r = 0.915,P<0.001。从这一系列研究中,我们得出结论,在这个急性尿毒症模型中,磷酸盐潴留是对PTH提取物钙调节作用产生抵抗的原因。